Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Ilika secures purchase order for Stereax electrodes

(Sharecast News) - Ilika said on Wednesday that it has secured its first revenue-generating purchase order for Stereax electrodes from Cirtec Medical, marking the commercial transition of the companies' strategic partnership after two years of development work. The AIM-traded solid-state battery specialist said the order covered supply of the conductive electrodes used in its Stereax M300 batteries and followed the successful delivery of prototype units in December.

It said the electrodes would support Cirtec's ramp-up of Stereax M300 production in the US, targeting applications across active implantable medical devices, including implanted sensors, neurostimulators, orthopaedic and orthodontic devices and ophthalmology applications.

Ilika said the order represented its entry into the commercial phase for its medical battery technology.

Under an agreement announced in August 2023, Ilika retained specific battery manufacturing processes at its UK facility as a service to Cirtec, while primary manufacturing of the Stereax M300 takes place at Cirtec's Massachusetts site.

With early batteries delivered late last year, the relationship had now progressed to Cirtec purchasing production quantities of electrodes from Ilika.

The Stereax M300 batteries were currently being evaluated by 21 customers.

"This marks an important transition from the earlier stages of technology transfer to commercial production coordinated from our facility here in the US," said Shawn Martin, vice president at Cirtec Medical.

Ilika chief executive Graeme Purdy said the receipt of the first commercial electrode order validated the "strong market momentum" building behind the Stereax technology.

"This revenue-generating phase of our partnership with Cirtec positions us to support their manufacturing scale-up while accelerating product integration across numerous high-value medical device applications," he said.

At 1458 GMT, shares in Ilika were up 2.33% at 37.35p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Air France-KLM submits bid for stake in Portugal's TAP
(Sharecast News) - Air France-KLM said it had submitted a non-binding offer to buy a minority stake in TAP Air Portugal as part of the Portuguese government's plan to privatise its national airline.
Sorted Group proposes to dispose of its main trading subsidiary
(Sharecast News) - Sorted Group announced a proposal to dispose of its main trading subsidiary Sorted Group Limited on Thursday, for a nominal £1, in a move that would see the company become an AIM cash shell and pursue a new acquisition-led strategy.
Speedy Hire warns on worsening market conditions despite strategic progress
(Sharecast News) - Tools and equipment hire company Speedy Hire said on Thursday that it had delivered "significant strategic progress" in FY26, highlighted by its "transformational" partnership with Proservice and continued momentum across its core operations, but also cautioned that trading conditions had deteriorated further in the final quarter amid budget uncertainty, geopolitical tensions and customer‑driven delays.
RBC Capital Markets upgrades Berkeley to 'outperform'
(Sharecast News) - Analysts at RBC Capital Markets upgraded housebuilder Berkeley from 'sector perform' to 'outperform' on Thursday, noting the group had "acted decisively" to the challenges it had faced.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.